首页> 外文期刊>Clinical and experimental pharmacology & physiology >Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.
【24h】

Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.

机译:霉酚酸酯的免疫抑制可减轻醋酸脱氧皮质酮盐酸盐高血压大鼠的高血压和白蛋白尿的发展。

获取原文
获取原文并翻译 | 示例
       

摘要

1. The interplay between the immune and renin-angiotensin systems is emerging as a crucial factor in the development and progression of hypertension. The aim of the present study was to determine the involvement of immune cells in the hypertension and renal injury produced by a non-angiotensin II-dependent form of hypertension, namely deoxycorticosterone acetate (DOCA)-salt-induced hypertension, in rats. 2. Male Sprague-Dawley rats underwent uninephrectomy and received either a sustained-release pellet of DOCA s.c. and 0.9% NaCl (saline) to drink for 21 days or a placebo pellet and water to drink for 21 days. Additional groups of DOCA-salt- and placebo-treated rats were treated concurrently with the immune suppressant mycophenolate mofetil (MMF; 30 mg/kg per day). Rats were placed in metabolic cages for 24 h urine collection prior to and at weekly intervals during the 21 day experimental period. 3. Mycophenolate mofetil significantly attenuated the development of hypertension in DOCA-salt rats compared with untreated DOCA-salt hypertensive rats (mean arterial pressure by telemetry on Day 18,146 +/- 7 vs 180 +/- 3 mmHg, respectively; P < 0.001), as well as proteinuria (87 +/- 27 vs 305 +/- 63 mg/day, respectively, on Day 21) and albuminuria (51 +/- 15 vs 247 +/- 73 mg/day, respectively, on Day 21). Creatinine clearance was better preserved in MMF-treated DOCA-salt rats compared with untreated DOCA-salt rats (0.74 +/- 0.07 vs 0.49 +/- 0.09 mL/min, respectively; P < 0.05), but was still significantly reduced compared with that in the placebo group (1.15 +/- 0.12 mL/min; P < 0.05). Finally, MMF treatment significantly attenuated the DOCA-salt-induced rise in renal cortical T-lymphocyte and macrophage infiltration (P < 0.05). 4. These data indicate that immune cells play a deleterious role in both the hypertension and renal injury associated with DOCA-salt hypertension.
机译:1.免疫系统与肾素-血管紧张素系统之间的相互作用正在成为高血压发展和进展的关键因素。本研究的目的是确定免疫细胞参与高血压和由非血管紧张素II依赖性形式的高血压(即脱氧皮质酮醋酸盐(DOCA)-盐诱导的高血压)引起的肾损伤。 2.雄性Sprague-Dawley大鼠接受单肾切除术,并接受DOCA s.c.的缓释微丸。饮用0.9%的氯化钠(盐水)饮用21天,或服用安慰剂颗粒和水饮用21天。用免疫抑制剂霉酚酸酯(MMF;每天30 mg / kg)同时治疗另外两组DOCA-盐和安慰剂治疗的大鼠。在21天实验期间,将大鼠放在新陈代谢的笼子中收集尿液24小时,然后每周一次。 3.与未经治疗的DOCA-盐高血压大鼠相比,霉酚酸酯显着减轻了DOCA-盐大鼠的高血压发展(第18,146 +/- 7天相对于180 +/- 3 mmHg的遥测平均动脉压; P <0.001) ,以及蛋白尿(第21天分别为87 +/- 27 vs 305 +/- 63 mg /天)和白蛋白尿(第21天分别为51 +/- 15 vs 247 +/- 73 mg /天)。与未处理的DOCA-盐大鼠相比,经MMF处理的DOCA-盐大鼠中的肌酐清除率保留得更好(分别为0.74 +/- 0.07 vs. 0.49 +/- 0.09 mL / min; P <0.05),但与安慰剂组(1.15 +/- 0.12 mL / min; P <0.05)。最后,MMF治疗显着减轻了DOCA盐引起的肾皮质T淋巴细胞和巨噬细胞浸润的升高(P <0.05)。 4.这些数据表明免疫细胞在高血压和与DOCA盐高血压相关的肾损伤中均起有害作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号